Penny L. Moore

17.0k citations

144 papers · 5.7k indexed · 2 hit papers · h-index 38

Virology top 0.1%
- HIV Research and Treatment 100
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 31
- SARS-CoV-2 and COVID-19 Research 21
- HIV/AIDS Research and Interventions 17
Immunology top 1%
- Immune Cell Function and Interaction 46
- T-cell and B-cell Immunology 17
Radiology, Nuclear Medicine and Imaging top 1%
- Monoclonal and Polyclonal Antibodies Research 31
Hepatology top 5%
Molecular Biology
- vaccines and immunoinformatics approaches 16

Co-authors: Lynn Morris Elin S. Gray Salim S. Abdool Karim Carolyn Williamson Constantinos Kurt Wibmer Koleka Mlisana Tandile Hermanus Bronwen E. Lambson
Cited by: Virology Infectious Diseases Immunology
Journals: New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
Partner nations: South Africa United States United Kingdom

In The Last Decade

Penny L. Moore

132 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Penny L. Moore

Since Specialization

Citations

This map shows the geographic impact of Penny L. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penny L. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penny L. Moore more than expected).

Fields of papers citing papers by Penny L. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penny L. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penny L. Moore. The network helps show where Penny L. Moore may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Penny L. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Penny L. Moore Line = papers co-authored together Penny L. Moore links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV – a review AIDS Research and Therapy ·Sharana Mahomed,Komala Pillay,Razia Hassan-Moosa,Bruna P. G. V. Galvão,Wendy A. Burgers,Penny L. Moore,Melissa Rose-Abrahams,Carolyn Williamson,Nigel Garrett	2025	4
2	SARS-CoV-2 Infections in a Triad of Primary School Learners (Grades 1-7), Their Parents, and Teachers in KwaZulu-Natal, South Africa: Protocol for a Cross-Sectional and Nested Case-Cohort Study JMIR Research Protocols ·Reshmi Dassaye,Terusha Chetty,Brodie Daniels,Zakir Gaffoor,Elizabeth Spooner,Trisha Ramraj,Ncengani Mthethwa,Duduzile Nsibande,Saresha Pillay,Arvin Bhana,Vuyolwethu Magasana,Tarylee Reddy,Khanya Mohlabi,Penny L. Moore,Wendy A. Burgers,Túlio de Oliveira,Nokukhanya Msomi,Ameena Goga	2024	0
3	Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza Vaccination The Journal of Infectious Diseases ·Boitumelo M. Motsoeneng,Nisha Dhar,Marta C. Nunes,Florian Krammer,Shabir A. Madhi,Penny L. Moore,Simone I. Richardson	2024	5
4	Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in golden Syrian hamsters Vaccine ·Yolandy Lemmer,Rosamund Chapman,Célia Abolnik,Tanja Smith,Georgia Schäfer,Tandile Hermanus,Ilse du Preez,Kruger Goosen,Kamogelo M. Sepotokele,Sophette Gers,Tasnim Suliman,Wolfgang Preiser,Megan L. Shaw,Robyn Roth,Alma Truyts,John Kudakwashe Chipangura,Martin Magwaza,Osborn Mahanjana,Penny L. Moore,Martha M. O’Kennedy	2024	2
5	301 Buprenorphine Induction in Emergency Department Patients Following Reversal of Non-Fatal Opioid Overdose With Naloxone Annals of Emergency Medicine ·Penny L. Moore,Sharon Chen,Ellen Almirol,Matthew J. Meyer,Changqing Luo,Jane L. Murray,Neeraj Chhabra	2023	1
6	Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines Journal of Virology ·Matthew J. Vukovich,Nagarajan Raju,Prudence Kgagudi,Nelia P. Manamela,Alexandra A. Abu-Shmais,Kathryn R. Gripenstraw,Perry T. Wasdin,Xiaoying Shen,Bridget Dwyer,Jumana Akoad,Rebecca M. Lynch,David C. Montefiori,Simone I. Richardson,Penny L. Moore,Ivelin S. Georgiev	2023	2
7	COVID-19 as a catalyst for vaccine manufacturing: A South African experience Cell Host & Microbe ·Penny L. Moore,Glenda Gray	2023	0
8	Building a Resilient Scientific Network for COVID-19 and Beyond mBio ·N. Esther Babady,Rachel M. Burckhardt,Florian Krammer,Penny L. Moore,Lynn W. Enquist	2022	1
9	Development and deployment of COVID-19 vaccines for those most vulnerable Science Translational Medicine ·Wayne C. Koff,Theodore Schenkelberg,Tere Williams,Ralph S. Baric,Adrian B. McDermott,Cheryl Cameron,Mark J. Cameron,Matthew B. Frieman,Gabriele Neumann,Yoshihiro Kawaoka,Alyson A. Kelvin,Ted M. Ross,Stacey Schultz‐Cherry,Timothy D. Mastro,Frances Priddy,Penny L. Moore,Julie Ostrowsky,Michael T. Osterholm,Jaap Goudsmit	2021	51
10	Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection mSphere ·Maximilian Muenchhoff,Amy W. Chung,Julia Roider,Anne‐Sophie Dugast,Simone I. Richardson,Henrik N. Kløverpris,Alasdair Leslie,Thumbi Ndung’u,Penny L. Moore,Galit Alter,Philip Goulder	2020	17
11	IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody PLoS Pathogens ·Simone I. Richardson,Bronwen E. Lambson,Andrew R. Crowley,Arman Bashirova,Cathrine Scheepers,Nigel Garrett,Salim S. Abdool Karim,Nonhlanhla N. Mkhize,Mary Carrington,Margaret E. Ackerman,Penny L. Moore,Lynn Morris	2019	53
12	Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage PLoS Pathogens ·Lucia Reh,Carsten Magnus,Claus Kadelka,Denise Kühnert,Therese Uhr,Jacqueline Weber,Lynn Morris,Penny L. Moore,Alexandra Trkola	2018	10
13	Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation Nature Communications ·E. L. Johnson,Nicole A. Doria‐Rose,Jason Gorman,Jinal N. Bhiman,Chaim A. Schramm,Ashley Q. Vu,William H. Law,Baoshan Zhang,Valerie Bekker,Salim S. Abdool Karim,Gregory C. Ippolito,Lynn Morris,Penny L. Moore,Peter D. Kwong,John R. Mascola,George Georgiou	2018	6
14	HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies PLoS Pathogens ·Simone I. Richardson,Amy W. Chung,Harini Natarajan,Batsirai Mabvakure,Nonhlanhla N. Mkhize,Nigel Garrett,Salim S. Abdool Karim,Penny L. Moore,Margaret E. Ackerman,Galit Alter,Lynn Morris	2018	56
15	Viral Escape Pathways from Broadly Neutralising Antibodies Targeting the HIV Envelope Cleavage Site Enhance MPER Mediated Neutralisation AIDS Research and Human Retroviruses ·Constantinos Kurt Wibmer,Daniel J. Sheward,Jinal N. Bhiman,Nonkululeko Ndabambi,Debra H. Elliot,Julie A. Rouelle,Ashley R. Smira,Salim S. Abdool Karim,James E. Robinson,Lynn Morris,Carolyn Williamson,Penny L. Moore	2014	1
16	N-Linked Glycan Modifications in gp120 of Human Immunodeficiency Virus Type 1 Subtype C Render Partial Sensitivity to 2G12 Antibody Neutralization Journal of Virology ·Elin S. Gray,Penny L. Moore,Ralph Pantophlet,Lynn Morris	2007	40
17	The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Human Immunodeficiency Virus Type 1 Subtype C Infection Journal of Virology ·Penny L. Moore,Elin S. Gray,Isaac Choge,Nthabeleng Ranchobe,Koleka Mlisana,Salim S. Abdool Karim,Carolyn Williamson,Lynn Morris	2007	125
18	Genotypic and Phenotypic Characterization of Viral Isolates from HIV-1 Subtype C-Infected Children with Slow and Rapid Disease Progression AIDS Research and Human Retroviruses ·Isaac Choge,Tonie Cilliers,Polly Walker,Natasha Taylor,Mary Phoswa,Tammy Meyers,Johannes Viljoen,Avy Violari,Glenda Gray,Penny L. Moore,Maria Papathanosopoulos,Lynn Morris	2006	45
19	In Vitro Generation of HIV Type 1 Subtype C Isolates Resistant to Enfuvirtide AIDS Research and Human Retroviruses ·Tonie Cilliers,Penny L. Moore,Mia Coetzer,Lynn Morris	2005	10
20	Prophylaxis against hepatitis A for travel. BMJ ·Penny L. Moore,Pippa Oakeshott,Jacqueline Logan,John Law,D. M. Harris	1990	7

About Penny L. Moore

Penny L. Moore is a scholar working on Virology, Infectious Diseases and Immunology, having authored 144 papers that have together received 5.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (100 papers), Immune Cell Function and Interaction (46 papers), HIV/AIDS drug development and treatment (31 papers), Monoclonal and Polyclonal Antibodies Research (31 papers), SARS-CoV-2 and COVID-19 Research (21 papers), HIV/AIDS Research and Interventions (17 papers), T-cell and B-cell Immunology (17 papers) and vaccines and immunoinformatics approaches (16 papers). The work is most often cited by research in Virology (3.2k citations), Infectious Diseases (2.8k citations) and Immunology (2.0k citations). Penny L. Moore has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Lynn Morris, Elin S. Gray, Salim S. Abdool Karim, Carolyn Williamson, Constantinos Kurt Wibmer, Koleka Mlisana, Tandile Hermanus, Bronwen E. Lambson, Michael T. Osterholm and Jinal N. Bhiman. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact